IQVIA Holdings | IQV - Cash And Equivalent


IQVIA Holdings reported $1.91B in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
Accenture USD 10.17B 766.06M Mar/2026
Agilent USD 1.81B 49M Mar/2026
Bruker USD 184.9M 51.5M Jun/2026
Cardinal Health USD 4.86B 919M Jun/2026
Celltrion KRW 56.79B 6.92B Mar/2026
Charles River Laboratories USD 192.02M 195K Jun/2026
Cigna USD 6.3B 742M Jun/2026
Cognizant Technology Solutions USD 1.04B 466M Jun/2026
Cspc Pharmaceutical CNY 6.09B 1.48B Dec/2025
CVS Health USD 11.33B 1.79B Jun/2026
Danaher USD 4.35B 1.35B Jun/2026
Dentsply International USD 239M 49M Jun/2026
Deva Holding AS TRY 775.92M 574.67M Sep/2023
Dianthus Therapeutics USD 110.55M 517.12M Jun/2026
Divis Laboratories Ltd INR 1.28B 2.87B Mar/2026
Elevance Health USD 10.23B 575M Jun/2026
Humana USD 6.89B 1.94B Jun/2026
IBM USD 7.17B 3.65B Jun/2026
Illumina USD 1.09B 329M Mar/2026
Infosys INR 92.7M 3.49B Mar/2026
Kangmei Pharma CNY 1.23B 48.16M Mar/2026
Knight Therapeutics CAD 76.45M 5.43M Dec/2025
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
Laboratory Of America USD 141.8M 839.3M Jun/2026
Malin Corporation EUR 62.1M 26.4M Dec/2024
McKesson USD 5.16B 1.19B Jun/2026
Mettler Toledo International USD 51.38M 9.19M Jun/2026
Organigram Holdings CAD 4.29M 3.28M Mar/2026
Pharma Mar EUR 19.34M 29.53M Jun/2026
Publicis EUR 4.03B 1.83B Dec/2025
Qiagen NV USD 646.29M 192.72M Mar/2026
Quest Diagnostics USD 626M 233M Jun/2026
Revvity USD 1.02B 162.62M Jun/2026
Sartorius EUR 291M 282.8M Jun/2026
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Tilray USD 264.83M 43.16M Jun/2025
UnitedHealth USD 31.47B 239M Jun/2026
Veeva Systems USD 1.9B 475.35M Mar/2026
Veradigm USD 492.6M 7.57M Sep/2022
Waters USD 539M 77M Jun/2026
Zealand Pharma A/S 3.85B 727.54M Mar/2026
Zz Pientze Pharmaceu CNY 1.96B 186.63M Mar/2026